
Report ID: SQMIG35I2281
Report ID:
SQMIG35I2281 |
Region:
Global |
Published Date: January, 2025
Pages:
157
|Tables:
63
|Figures:
65
Acne Medication Market size was valued at USD 11.1 billion in 2023 and is poised to grow from USD 12.03 billion in 2024 to USD 22.94 billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).
Acne is one of the most common skin conditions globally, affecting millions of people across all age groups. The high prevalence of acne has been a significant driver of the demand for acne medication. Increasing awareness about skin health, appearance, and self-care among the general population has led to a growing demand for effective acne treatment solutions.
Ongoing research and development in dermatology and pharmaceuticals have led to the introduction of new and more effective acne medications. Advancements in topical formulations, oral medications, and combination therapies have expanded treatment options. Modern lifestyles, including factors such as stress, dietary habits, and pollution, have been linked to acne development. As people seek solutions for skin issues resulting from lifestyle factors, the demand for acne medication rises.
US Acne Medication Market is poised to grow at a sustainable CAGR for the next forecast year.
To get more reports on the above market click here to Buy The Report
Global Acne Medication Market is segmented by Product, Type, Route of Administration, Age Group, Distribution Channel and region. Based on Product, the market is segmented into Topical Retinoids, Oral Antibiotics, Oral Retinoids, Over-the-Counter (OTC) Drugs, Isotretinoin and Others. Based on Type, the market is segmented into Inflammatory Acne and Non-inflammatory Acne. Based on Route of Administration, the market is segmented into Topical, Oral and Injectable. Based on Age Group, the market is segmented into 10 to 17 Years, 18 to 44 Years, 45 to 64 Years and 65 Years & Above. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
In 2022, the antibiotics segment held a dominant position in the market due to the increasing approval of antibiotics for treating acne and its effectiveness in managing exudate. As a result, antibiotics became the leading product category in the global market, contributing significantly to its overall value.
However, looking ahead, the retinoids segment is expected to show a higher compound annual growth rate (CAGR) by 2030. This projection is primarily attributed to the rising prevalence of moderate to severe acne, which is driving the demand for retinoid-based treatments. An example of this trend is reflected in the February 2020 announcement by Sun Pharmaceutical Industries Ltd., wherein they launched ABSORICA LD (Isotretinoin) capsules in the U.S. for managing severe recalcitrant nodular acne in patients aged 12 and older.
The topical segment is expected to hold the dominant position in the market throughout the forecast period. The growth of this segment can be attributed to the rising number of companies manufacturing topical solutions for acne treatment. This is mainly due to the significant patient population suffering from acne, who are particularly interested in topical solutions because they are easily accessible and comfortable to use.
On the other hand, the oral segment is predicted to experience substantial growth with a significant Compound Annual Growth Rate (CAGR) during the forecast period. This growth is driven by the increasing prevalence of acne and the continuous introduction of new acne treatment products. For instance, Almirall, S.A. launched Seysara in January 2019, which is the first oral antibiotic specifically developed for acne treatment in the U.S.
To get detailed analysis on other segments, Request For Free Sample Report
North America has emerged as the dominant player in the global acne treatment market, capturing an impressive 35.9% share of the market revenue in 2022. This market leadership is expected to continue during the projected years due to several key factors. One of the primary drivers is the region's growing prevalence of acne-related issues and increasing consumer concerns about beauty and skincare. The continuous efforts of major players in the region to introduce new and innovative acne treatment products will also contribute significantly to market growth. Additionally, a substantial rise in the number of patients seeking treatment for acne-related problems will further fuel the market's expansion in North America.
Similarly, Europe is projected to witness substantial growth and make a significant global contribution to the acne treatment market. This growth will be driven by the region's increasing pool of patients seeking dermatology treatments and a growing focus on investing in research and development for addressing skin-related issues. The adoption of advanced and cutting-edge acne treatment solutions in Europe will play a crucial role in propelling the market share to higher levels. With both North America and Europe making significant strides in the acne treatment market, the global industry is set to witness robust growth and advancements in the coming years.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Occurrence of Acne Globally
Side Effects Pertaining to Current Marketed Drugs is Limiting Adoption
Request Free Customization of this report to help us to meet your business objectives.
The market is characterized by a multitude of major players that provide a wide range of pharmaceutical drugs. These prominent companies hold strong revenue positions and boast diverse product portfolios. They have established a firm presence in key growth regions. Among the dominant players are Allergan, Galderma S.A., and Bausch Health Companies Inc. For example, in April 2021, Bausch Health Companies Inc. announced significant positive results from its Phase 3 trials for IDP-126 Gel, a treatment for Acne Vulgaris.
Alongside these major players, there are smaller companies operating with a more limited product range. These companies have a strong presence at the national level and are expected to expand their operations during the forecast period.
SkyQuest's ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global acne medication market analyses, globally, the prevalence of skin conditions has experienced a notable surge, particularly regarding acne. Conversely, there are promising opportunities for market expansion due to the rise in research and development activities in the skincare industry. Moreover, untapped emerging markets offer high market potential, further bolstering growth prospects. The increasing prevalence and severity of acne will also play a significant role in driving the market's size during the forecast period.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 11.1 billion |
Market size value in 2032 | USD 22.94 billion |
Growth Rate | 8.4% |
Base year | 2024 |
Forecast period | 2025-2032 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Acne Medication Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Acne Medication Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Acne Medication Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Acne Medication Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Acne Medication Market size was valued at USD 10.28 Billion in 2023 and is poised to grow from USD 10.77 Billion in 2024 to USD 15.67 Billion by 2032, growing at a CAGR of 4.8% during the forecast period (2025-2032).
The market is characterized by a multitude of major players that provide a wide range of pharmaceutical drugs. These prominent companies hold strong revenue positions and boast diverse product portfolios. They have established a firm presence in key growth regions. Among the dominant players are Allergan, Galderma S.A., and Bausch Health Companies Inc. For example, in April 2021, Bausch Health Companies Inc. announced significant positive results from its Phase 3 trials for IDP-126 Gel, a treatment for Acne Vulgaris. 'Allergan (Ireland)', 'Botanix Pharmaceuticals (Australia)', 'GALDERMA (Switzerland)', 'Bausch Health Companies Inc. (U.S.) ', 'GlaxoSmithKline Plc. (U.K.)', 'Bayer AG (Germany)', 'Valeant Pharmaceutical International, Inc. (U.S.)', 'Johnson & Johnson Services, Inc. (U.S.)', 'Pfizer Inc. (U.S.)', 'Teva Pharmaceutical Industries Ltd. (Israel)'
The escalating demand for treatment options has been met with the introduction of a wide array of products designed for acne treatment, including retinoids, isotretinoins, and oral and topical antibiotics. These offerings have played a crucial role in enhancing awareness among the global population about acne products and available treatment choices, consequently fostering the growth of the market.
The global acne medication market is experiencing significant growth, driven by various factors such as changing hormone levels, a rising teenage population, and an increasing adoption of skincare products. Additionally, the occurrence of acne, which is caused by excessive oil production from sebaceous glands and an unhygienic lifestyle, is positively influencing market growth.
North America has emerged as the dominant player in the global acne treatment market, capturing an impressive 35.9% share of the market revenue in 2022. This market leadership is expected to continue during the projected years due to several key factors. One of the primary drivers is the region's growing prevalence of acne-related issues and increasing consumer concerns about beauty and skincare. The continuous efforts of major players in the region to introduce new and innovative acne treatment products will also contribute significantly to market growth. Additionally, a substantial rise in the number of patients seeking treatment for acne-related problems will further fuel the market's expansion in North America.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35I2281
[email protected]
USA +1 351-333-4748